Is Enliven Therapeutics, Inc. technically bullish or bearish?

Nov 04 2025 11:36 AM IST
share
Share Via
As of October 31, 2025, Enliven Therapeutics, Inc. shows a bullish technical trend, with mixed indicators including a bullish weekly MACD and bearish weekly Bollinger Bands, while underperforming the S&P 500 over the past year and year-to-date.
As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. Daily moving averages indicate a mildly bullish stance. However, the weekly Bollinger Bands are bearish, and both the KST and Dow Theory show a mildly bullish trend on the weekly and monthly time frames.

In terms of performance, the stock has underperformed the S&P 500 over the past year and year-to-date, with returns of -27.61% and -11.11% respectively, while the S&P 500 has returned 19.89% and 16.30%. Overall, the current technical stance is bullish, but the strength is mixed due to conflicting indicators.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News